‘
As the consensus about statins as cholesterol-lowering “miracle drugs” starts to crack, Big Pharma is doubtless looking for ways to preserve the profitability of the top-earning drug class of all time. Now, a new study in the journal Breast Cancer Research may indicate how statins will soon be marketed: as anti-cancer drugs.
The study was released shortly after yet another study challenging the effectiveness of statins, this one in the journal BMJ Open.
“Lowering cholesterol with medications for primary cardiovascular prevention in those aged over 60 is a total waste of time and resources, whereas altering your lifestyle is the single most important way to achieve a good quality of life,” said researcher Professor Sherif Sultan of the University of Ireland.’